Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab for Persistent New Vessels in Diabetic Retinopathy (INIPE)
NCT00993525Phase 2Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Sep 2008
- Primary completion
- Mar 2010
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of ranibizumab in proliferative diabetic retinopathy (PDR), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT00993525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993525.